Iterative approach for the development of a CNS-active oxime reactivator for nerve agent exposure

被引：0
|
作者：
Malfatti, Michael [1 ]
Bennion, Brian [1 ]
Enright, Heather [2 ]
Be, Nicholas [1 ]
Hok, Saphon [3 ,6 ]
Cadieux, C. [4 ]
Carpenter, Timothy [1 ]
Lao, Victoria [1 ]
Kuhn, Edward [1 ]
McNerney, Margaret [5 ]
Lightstone, Felice [1 ]
Tuan Nguyen
Valdez, Carlos [3 ,6 ]
机构：
[1] Lawrence Livermore Natl Lab, Biosci & Biotechnol, Livermore, CA 94550 USA
[2] Lawrence Livermore Natl Lab, Biosci & Biotechnol, Livermore, CA 94550 USA
[3] Lawrence Livermore Natl Lab, Nucl & Chem Sci, Livermore, CA 94550 USA
[4] US Army, Med Res Inst Chem Def, Aberdeen, MD USA
[5] War Related Illness & Injury Study Ctr, Vet Affairs, Palo Alto, CA USA
[6] Lawrence Livermore Natl Lab, Forens Sci Ctr, Livermore, CA 94550 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
45
引用
收藏
页数：1
相关论文
共 31 条
  • [1] Development of a CNS-permeable reactivator for nerve agent exposure: an iterative, multi-disciplinary approach
    Brian J. Bennion
    Michael A. Malfatti
    Nicholas A. Be
    Heather A. Enright
    Saphon Hok
    C. Linn Cadieux
    Timothy S. Carpenter
    Victoria Lao
    Edward A. Kuhn
    M. Windy McNerney
    Felice C. Lightstone
    Tuan H. Nguyen
    Carlos A. Valdez
    Scientific Reports, 11
  • [2] Development of a CNS-permeable reactivator for nerve agent exposure: an iterative, multi-disciplinary approach
    Bennion, Brian J.
    Malfatti, Michael A.
    Be, Nicholas A.
    Enright, Heather A.
    Hok, Saphon
    Cadieux, C. Linn
    Carpenter, Timothy S.
    Lao, Victoria
    Kuhn, Edward A.
    McNerney, M. Windy
    Lightstone, Felice C.
    Nguyen, Tuan H.
    Valdez, Carlos A.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] CNS-active reactivator of inhibited acetylcholinesterase provides neuroprotection in mice exposed to nerve agent
    Kovarik, Zrinka
    Hrvat, Nikolina Macek
    Ilic, Katarina
    Kolic, Dora
    Taylor, Palmer
    Bognar, Svjetlana Kalanj
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 161 - 162
  • [4] Evaluating the efficacy of a novel oxime reactivator against nerve agent exposure
    Enright, Heather
    Malfatti, Michael
    Kuhn, Edward
    Hok, Saphon
    Lao, Victoria
    Be, Nicholas
    Carpenter, Timothy
    Bennion, Brian
    Tuan Nguyen
    Valdez, Carlos
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [5] BACLOFEN (BF) - UNUSUAL CNS-ACTIVE AGENT
    BERNARD, P
    EDWARDS, SJ
    FIELDING, S
    ROBSON, RD
    SAELENS, JK
    SIMKE, JP
    WELCH, J
    PHARMACOLOGIST, 1975, 17 (02): : 256 - 256
  • [6] Perinatal Exposure to CNS-Active MedicationsNeurodevelopmental Risks
    M. Renée Simar
    CNS Drugs, 1999, 12 : 451 - 470
  • [7] New approach to development of low-dose CNS-active drug
    Tolstikova, TG
    Bryzgalov, AO
    Sorokina, IV
    Tolstikov, SE
    Kovalenko, IL
    Avgustinovich, DF
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S125 - S125
  • [8] Perinatal exposure to CNS-active medications - Neurodevelopmental risks
    Simar, MR
    CNS DRUGS, 1999, 12 (06) : 451 - 470
  • [9] Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase
    de Koning, Martijn Constantijn
    Horn, Gabriele
    Worek, Franz
    van Grol, Marco
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 151 - 160
  • [10] Cholesterol oxime olesoxime (TRO19622) as a potential reactivator of nerve agent-inhibited cholinesterases
    Kolic, D.
    Sinko, G.
    Jean, L.
    Chioua, M.
    Dias, J.
    Marco-Contelles, J.
    Kovarik, Z.
    FEBS OPEN BIO, 2022, 12 : 132 - 132
1234